Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breast Carcinoma
|
2793 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.100 | 0.632 | 19 | 2002 | 2019 | |||||
Malignant neoplasm of breast
|
3417 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.100 | 0.632 | 19 | 2002 | 2019 | |||||
Malignant neoplasm of prostate
|
1082 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.100 | 0.900 | 10 | 2000 | 2018 | |||||
Prostate carcinoma
|
1168 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.100 | 0.900 | 10 | 2000 | 2018 | |||||
Carcinoma of lung
|
1204 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.090 | 1.000 | 9 | 2005 | 2016 | |||||
Malignant neoplasm of lung
|
1142 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.090 | 1.000 | 9 | 2005 | 2016 | |||||
Primary malignant neoplasm of lung
|
981 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.090 | 1.000 | 9 | 2005 | 2016 | |||||
Colorectal Carcinoma
|
1962 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.050 | 1.000 | 5 | 2007 | 2018 | |||||
Endometrial Carcinoma
|
326 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.050 | 1.000 | 5 | 2004 | 2015 | |||||
Malignant neoplasm of endometrium
|
197 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.050 | 1.000 | 5 | 2004 | 2015 | |||||
Malignant Neoplasms
|
1641 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.040 | 1.000 | 4 | 2010 | 2015 | |||||
Uterine Fibroids
|
154 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.040 | 1.000 | 4 | 2011 | 2017 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.030 | 1.000 | 3 | 2010 | 2014 | |||||
Primary malignant neoplasm
|
1374 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.030 | 1.000 | 3 | 2010 | 2015 | |||||
Bladder Neoplasm
|
281 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.020 | 0.500 | 2 | 2013 | 2014 | |||||
Carcinoma of bladder
|
309 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.020 | 0.500 | 2 | 2013 | 2014 | |||||
Malignant neoplasm of urinary bladder
|
316 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.020 | 0.500 | 2 | 2013 | 2014 | |||||
Menopausal symptom
|
4 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.020 | 1.000 | 2 | 2012 | 2018 | |||||
Adenocarcinoma of lung (disorder)
|
563 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Adult Meningioma
|
30 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Adult Non-Hodgkin Lymphoma
|
39 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Ankylosing spondylitis
|
609 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Asthma
|
1536 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Carcinogenesis
|
355 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Carcinoma of larynx
|
65 | 0.581 | 0.680 | 2 | 38071060 | missense variant | G/C | snv | 0.51 | 0.010 | 1.000 | 1 | 2015 | 2015 |